| J9144 | Injection, daratumumab, 10 mg and hyaluronidase‑fihj | 12,420 | $40 | $472K |
| J9271 | Injection, pembrolizumab, 1 mg | 7,500 | $40 | $322.5K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 820 | $80 | $61.4K |
| Q5119 | Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg | 1,470 | $20 | $32.3K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 240 | $120 | $28.7K |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 9,260 | $1 | $18.5K |
| 99233 | The provider sees a patient for a subsequent hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a high level of medical decision making or the… | 150 | $100 | $14.6K |
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 1,390 | $10 | $13.9K |
| 96401 | The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient. | 170 | $70 | $11.4K |
| 83883 | The lab analyst performs a test to measure the amount of an analyte, not elsewhere specified, through nephelometry, in the patient specimen. | 860 | $10 | $11.2K |